These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9698466)

  • 41. [Study of the mutation and expression of PTEN gene in endometrial carcinoma and epithelial ovarian cancer].
    Che Y; Yao Q; Dai S; Luo B; Wang Y
    Zhonghua Fu Chan Ke Za Zhi; 2002 Oct; 37(10):608-11. PubMed ID: 12487936
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Frequent inactivation of PTEN in prostate cancer cell lines and xenografts.
    Vlietstra RJ; van Alewijk DC; Hermans KG; van Steenbrugge GJ; Trapman J
    Cancer Res; 1998 Jul; 58(13):2720-3. PubMed ID: 9661880
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Assessment of the quality and frequency of mutations occurrence in PTEN gene in endometrial carcinomas and hyperplasias.
    Konopka B; Paszko Z; Janiec-Jankowska A; Goluda M
    Cancer Lett; 2002 Apr; 178(1):43-51. PubMed ID: 11849740
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [An approach to early genetic alterations in precancerous cells].
    Sato N; Nishida M; Noguchi M
    Hum Cell; 2000 Sep; 13(3):103-8. PubMed ID: 11197771
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genetic pathways of colorectal carcinogenesis rarely involve the PTEN and LKB1 genes outside the inherited hamartoma syndromes.
    Wang ZJ; Taylor F; Churchman M; Norbury G; Tomlinson I
    Am J Pathol; 1998 Aug; 153(2):363-6. PubMed ID: 9708796
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The PTEN tumour suppressor gene and malignant melanoma.
    Böni R; Vortmeyer AO; Burg G; Hofbauer G; Zhuang Z
    Melanoma Res; 1998 Aug; 8(4):300-2. PubMed ID: 9764804
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Detection of mutation and protein expression of PTEN gene in endometrial carcinoma].
    Xu B; Yao Q; Dai SZ
    Ai Zheng; 2004 Jan; 23(1):69-73. PubMed ID: 14720379
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Research on the mechanisms of PTEN gene inactivation in ovarian cancer].
    Lü QJ; Zhao XD; Song JY; Li XH; Ma Y; Meng H; Jiang WG
    Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):266-9. PubMed ID: 16181546
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PTEN and other tumor suppressor gene mutations as secondary genetic alterations in synovial sarcoma.
    Saito T; Oda Y; Kawaguchi K; Takahira T; Yamamoto H; Tanaka K; Matsuda S; Sakamoto A; Iwamoto Y; Tsuneyoshi M
    Oncol Rep; 2004 May; 11(5):1011-5. PubMed ID: 15069540
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Detection of mutation in exon 5 and exon 8 of PTEN in laryngeal squamous cell carcinoma].
    Bai WL; Gao H; Ren Z; Pan ZM
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Jan; 39(1):13-6. PubMed ID: 15127561
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Analysis of the 10q23 chromosomal region and the PTEN gene in human sporadic breast carcinoma.
    Feilotter HE; Coulon V; McVeigh JL; Boag AH; Dorion-Bonnet F; Duboué B; Latham WC; Eng C; Mulligan LM; Longy M
    Br J Cancer; 1999 Feb; 79(5-6):718-23. PubMed ID: 10070859
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers.
    Steck PA; Pershouse MA; Jasser SA; Yung WK; Lin H; Ligon AH; Langford LA; Baumgard ML; Hattier T; Davis T; Frye C; Hu R; Swedlund B; Teng DH; Tavtigian SV
    Nat Genet; 1997 Apr; 15(4):356-62. PubMed ID: 9090379
    [TBL] [Abstract][Full Text] [Related]  

  • 53. PTEN/MMAC1 mutations in hepatocellular carcinomas.
    Yao YJ; Ping XL; Zhang H; Chen FF; Lee PK; Ahsan H; Chen CJ; Lee PH; Peacocke M; Santella RM; Tsou HC
    Oncogene; 1999 May; 18(20):3181-5. PubMed ID: 10340391
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Homozygous deletion of the PTEN tumor-suppressor gene is not a feature in oral squamous cell carcinoma.
    Chen Q; Samaranayake LP; Zhou H; Xiao L
    Oral Oncol; 2000 Jan; 36(1):95-9. PubMed ID: 10889927
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genetics of Cowden syndrome: through the looking glass of oncology.
    Eng C
    Int J Oncol; 1998 Mar; 12(3):701-10. PubMed ID: 9472113
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PTEN mutations in gliomas and glioneuronal tumors.
    Duerr EM; Rollbrocker B; Hayashi Y; Peters N; Meyer-Puttlitz B; Louis DN; Schramm J; Wiestler OD; Parsons R; Eng C; von Deimling A
    Oncogene; 1998 Apr; 16(17):2259-64. PubMed ID: 9619835
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mutation analysis of the BRCA1 gene in ovarian cancers.
    Takahashi H; Behbakht K; McGovern PE; Chiu HC; Couch FJ; Weber BL; Friedman LS; King MC; Furusato M; LiVolsi VA
    Cancer Res; 1995 Jul; 55(14):2998-3002. PubMed ID: 7606717
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification and allelic frequencies of novel single-nucleotide polymorphisms in the DUSP1 and BTG1 genes.
    Suzuki C; Unoki M; Nakamura Y
    J Hum Genet; 2001; 46(3):155-7. PubMed ID: 11310585
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mutational analysis of the PTEN gene in head and neck squamous cell carcinoma.
    Shao X; Tandon R; Samara G; Kanki H; Yano H; Close LG; Parsons R; Sato T
    Int J Cancer; 1998 Aug; 77(5):684-8. PubMed ID: 9688299
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mutations of PTEN/MMAC1 in primary prostate cancers from Chinese patients.
    Dong JT; Li CL; Sipe TW; Frierson HF
    Clin Cancer Res; 2001 Feb; 7(2):304-8. PubMed ID: 11234884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.